Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. United States
  4. Nasdaq
  5. BeiGene, Ltd.
  6. Revisions
    BGNE   US07725L1026

BEIGENE, LTD.

(BGNE)
  Report
Delayed Nasdaq  -  04:00:00 2023-02-01 pm EST
254.28 USD   -0.67%
02/01BeiGene to Present at Upcoming Investor Conferences
BU
01/31Beigene, Ltd. : Entry into a Material Definitive Agreement, Financial Statements and Exhibits (form 8-K)
AQ
01/24Morgan Stanley Adjusts Price Target on BeiGene to $325 From $295, Maintains Overweight Rating
MT
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
Earnings Per Share (EPS): Change in analysts' estimates
Turnover: Change in analysts' estimates
EPS consensus revisions
Next year EPS consensus revisions
Revenue consensus revisions
Next year Revenue consensus revisions